Results 151 to 160 of about 8,567 (186)
Some of the next articles are maybe not open access.
A Newly Released SNRI for Treatment of Fibromyalgia
Current Psychiatry Reports, 2010Milnacipran is a dual norepinephrine and serotonin reuptake inhibitor (SNRI) that was recently approved by the US Food and Drug Administration for the treatment of fibromyalgia (FM). SNRIs are frequently used, along with graded exercise and cognitive-behavioral therapy, to treat FM.
openaire +2 more sources
Serotonin-Noradrenalin-selektive Antidepressiva (SNRI/NaSSA)
2002Zu den Antidepressiva, die selektiv sowohl auf das serotonerge als auch auf das noradrenerge System wirken, zahlen: Milnacipran Mirtazapin ...
G. Laux +4 more
openaire +1 more source
Treating Depression with SNRIs: Who Will Benefit Most?
CNS Spectrums, 2008AbstractThere is evidence that the serotonin norepinephrine reuptake inhibitors (SNRIs) venlafaxine, milnacipran, and duloxetine, have probable superior antidepressant activity to most selective serotonin reuptake inhibitors (SSRIs), especially in more severe depression. Some patients, however, respond better than others to SNRIs.
openaire +2 more sources
A review of SSRIs and SNRIs in neuropathic pain
Expert Opinion on Pharmacotherapy, 2010Selective serotonin reuptake inhibitors (SSRIs) and serotonin noradrenaline reuptake inhibitors (SNRIs) are becoming increasingly used in the treatment of neuropathic pain and fibromyalgia. However, they are not without adverse effects and their efficacy has not been clear because of conflicting evidence.We have examined the current evidence on the ...
Yee-Chi, Lee, Phoon-Ping, Chen
openaire +2 more sources
SSRIs vs. SNRIs for anxiety and OCD
The Brown University Child and Adolescent Behavior Letter, 2020Selective serotonin reuptake inhibitors (SSRIs) have greater adverse event (AE)–related discontinuation of treatment than serotonin‐norepinephrine reuptake inhibitors (SNRIs) in the treatment of pediatric obsessive‐compulsive disorder (OCD) and anxiety disorders. And SSRIs are more likely than SNRIs to produce “activation” (restlessness).
openaire +1 more source
Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia syndrome
Cochrane Database of Systematic Reviews, 2013Fibromyalgia syndrome (FMS) is a clinically well-defined chronic condition of unknown etiology characterized by chronic widespread pain that often co-exists with sleep disturbances, cognitive dysfunction and fatigue. Patients often report high disability levels and poor quality of life (QOL).
Winfried, Häuser +4 more
openaire +2 more sources
Effect of SSRIs and SNRIs on Nocturnal Urinary Frequency
Annals of Pharmacotherapy, 2016Background: Existing data suggest that selective serotonin uptake inhibitors (SSRIs) may have an impact on urinary frequency. Objective: To evaluate the impact of SSRIs and selective noradrenaline reuptake inhibitors (SNRIs) on nocturnal urinary frequency.
Boris I, Medarov +4 more
openaire +2 more sources
[Serotonin-noradrenaline reuptake inhibitors(SNRIs)].
Nihon rinsho. Japanese journal of clinical medicine, 2001Pharmacology, clinical efficacy and tolerability of serotonin noradrenaline reuptake inhibitors(SNRIs) are overviewed. They include milnacipran, venlafaxine, duloxetine, MCI-225 and nefazodone, however, only milnacipran is currently used in Japan.
openaire +1 more source